Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves

Dale A. Moore, Edward R Atwill, John H. Kirk, Dipa Brahmbhatt, Laura Herrera Alonso, Lingling Hou, Matthew D. Singer, Tracy D. Miller

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective - To evaluate the effect of daily oral administration of decoquinate to neonatal calves experimentally challenged with various numbers of Cryptosporidium parvum oocysts. Design - Clinical trial. Animals - 75 calves. Procedure - Calves were purchased from a commercial dairy during a 5-week period. Calves were housed in individual hutches and fed milk replacer with or without decoquinate (2 mg/kg [0.9 mg/lb per day]). Calves were randomly assigned to treatment and 1 of 5 challenge groups (0, 50, 100, 1000, or 10,000 C parvum oocysts in 60 mL of saline [0.9% NaCl] solution administered PO on the day after arrival). Calves were maintained in the study for as long as 28 days. Calves were clinically assessed for diarrhea and dehydration. Fecal samples were submitted for oocyst enumeration 3 times each week. Results - Treatment did not affect number of days to first watery feces (diarrhea), number of days to first oocyst shedding, or duration of diarrhea or oocyst shedding. Duration of oocyst shedding was significantly associated with challenge dose of oocysts administered to calves and number of days to first oocyst shedding. Duration of diarrhea and number of days to first oocyst shedding were significantly associated with week of arrival and number of days to first watery diarrhea. Conclusions and Clinical Relevance - Daily treatment with decoquinate at the dosage used in this study did not affect oocyst shedding or clinical signs associated with cryptosporidiosis. However, there was an indication that if the number of oocysts calves received could be reduced, then the duration of oocyst shedding and, hence, environmental loading of C parvum oocysts could be reduced.

Original languageEnglish (US)
Pages (from-to)839-845
Number of pages7
JournalJournal of the American Veterinary Medical Association
Volume223
Issue number6
DOIs
StatePublished - Sep 15 2003

Fingerprint

Decoquinate
decoquinate
Cryptosporidium parvum
Oocysts
oocysts
calves
Infection
infection
Diarrhea
diarrhea
duration
Cryptosporidiosis
cryptosporidiosis
milk replacer

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves. / Moore, Dale A.; Atwill, Edward R; Kirk, John H.; Brahmbhatt, Dipa; Alonso, Laura Herrera; Hou, Lingling; Singer, Matthew D.; Miller, Tracy D.

In: Journal of the American Veterinary Medical Association, Vol. 223, No. 6, 15.09.2003, p. 839-845.

Research output: Contribution to journalArticle

Moore, Dale A. ; Atwill, Edward R ; Kirk, John H. ; Brahmbhatt, Dipa ; Alonso, Laura Herrera ; Hou, Lingling ; Singer, Matthew D. ; Miller, Tracy D. / Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves. In: Journal of the American Veterinary Medical Association. 2003 ; Vol. 223, No. 6. pp. 839-845.
@article{ce0160cc005b40e199179b8106687aeb,
title = "Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves",
abstract = "Objective - To evaluate the effect of daily oral administration of decoquinate to neonatal calves experimentally challenged with various numbers of Cryptosporidium parvum oocysts. Design - Clinical trial. Animals - 75 calves. Procedure - Calves were purchased from a commercial dairy during a 5-week period. Calves were housed in individual hutches and fed milk replacer with or without decoquinate (2 mg/kg [0.9 mg/lb per day]). Calves were randomly assigned to treatment and 1 of 5 challenge groups (0, 50, 100, 1000, or 10,000 C parvum oocysts in 60 mL of saline [0.9{\%} NaCl] solution administered PO on the day after arrival). Calves were maintained in the study for as long as 28 days. Calves were clinically assessed for diarrhea and dehydration. Fecal samples were submitted for oocyst enumeration 3 times each week. Results - Treatment did not affect number of days to first watery feces (diarrhea), number of days to first oocyst shedding, or duration of diarrhea or oocyst shedding. Duration of oocyst shedding was significantly associated with challenge dose of oocysts administered to calves and number of days to first oocyst shedding. Duration of diarrhea and number of days to first oocyst shedding were significantly associated with week of arrival and number of days to first watery diarrhea. Conclusions and Clinical Relevance - Daily treatment with decoquinate at the dosage used in this study did not affect oocyst shedding or clinical signs associated with cryptosporidiosis. However, there was an indication that if the number of oocysts calves received could be reduced, then the duration of oocyst shedding and, hence, environmental loading of C parvum oocysts could be reduced.",
author = "Moore, {Dale A.} and Atwill, {Edward R} and Kirk, {John H.} and Dipa Brahmbhatt and Alonso, {Laura Herrera} and Lingling Hou and Singer, {Matthew D.} and Miller, {Tracy D.}",
year = "2003",
month = "9",
day = "15",
doi = "10.2460/javma.2003.223.839",
language = "English (US)",
volume = "223",
pages = "839--845",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "6",

}

TY - JOUR

T1 - Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves

AU - Moore, Dale A.

AU - Atwill, Edward R

AU - Kirk, John H.

AU - Brahmbhatt, Dipa

AU - Alonso, Laura Herrera

AU - Hou, Lingling

AU - Singer, Matthew D.

AU - Miller, Tracy D.

PY - 2003/9/15

Y1 - 2003/9/15

N2 - Objective - To evaluate the effect of daily oral administration of decoquinate to neonatal calves experimentally challenged with various numbers of Cryptosporidium parvum oocysts. Design - Clinical trial. Animals - 75 calves. Procedure - Calves were purchased from a commercial dairy during a 5-week period. Calves were housed in individual hutches and fed milk replacer with or without decoquinate (2 mg/kg [0.9 mg/lb per day]). Calves were randomly assigned to treatment and 1 of 5 challenge groups (0, 50, 100, 1000, or 10,000 C parvum oocysts in 60 mL of saline [0.9% NaCl] solution administered PO on the day after arrival). Calves were maintained in the study for as long as 28 days. Calves were clinically assessed for diarrhea and dehydration. Fecal samples were submitted for oocyst enumeration 3 times each week. Results - Treatment did not affect number of days to first watery feces (diarrhea), number of days to first oocyst shedding, or duration of diarrhea or oocyst shedding. Duration of oocyst shedding was significantly associated with challenge dose of oocysts administered to calves and number of days to first oocyst shedding. Duration of diarrhea and number of days to first oocyst shedding were significantly associated with week of arrival and number of days to first watery diarrhea. Conclusions and Clinical Relevance - Daily treatment with decoquinate at the dosage used in this study did not affect oocyst shedding or clinical signs associated with cryptosporidiosis. However, there was an indication that if the number of oocysts calves received could be reduced, then the duration of oocyst shedding and, hence, environmental loading of C parvum oocysts could be reduced.

AB - Objective - To evaluate the effect of daily oral administration of decoquinate to neonatal calves experimentally challenged with various numbers of Cryptosporidium parvum oocysts. Design - Clinical trial. Animals - 75 calves. Procedure - Calves were purchased from a commercial dairy during a 5-week period. Calves were housed in individual hutches and fed milk replacer with or without decoquinate (2 mg/kg [0.9 mg/lb per day]). Calves were randomly assigned to treatment and 1 of 5 challenge groups (0, 50, 100, 1000, or 10,000 C parvum oocysts in 60 mL of saline [0.9% NaCl] solution administered PO on the day after arrival). Calves were maintained in the study for as long as 28 days. Calves were clinically assessed for diarrhea and dehydration. Fecal samples were submitted for oocyst enumeration 3 times each week. Results - Treatment did not affect number of days to first watery feces (diarrhea), number of days to first oocyst shedding, or duration of diarrhea or oocyst shedding. Duration of oocyst shedding was significantly associated with challenge dose of oocysts administered to calves and number of days to first oocyst shedding. Duration of diarrhea and number of days to first oocyst shedding were significantly associated with week of arrival and number of days to first watery diarrhea. Conclusions and Clinical Relevance - Daily treatment with decoquinate at the dosage used in this study did not affect oocyst shedding or clinical signs associated with cryptosporidiosis. However, there was an indication that if the number of oocysts calves received could be reduced, then the duration of oocyst shedding and, hence, environmental loading of C parvum oocysts could be reduced.

UR - http://www.scopus.com/inward/record.url?scp=0041815980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041815980&partnerID=8YFLogxK

U2 - 10.2460/javma.2003.223.839

DO - 10.2460/javma.2003.223.839

M3 - Article

VL - 223

SP - 839

EP - 845

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 6

ER -